Search Results - "Horinaka, Shigeo"

Refine Results
  1. 1

    Use of Nicorandil in Cardiovascular Disease and Its Optimization by Horinaka, Shigeo

    Published in Drugs (New York, N.Y.) (01-06-2011)
    “…Nicorandil, a unique dual pharmacological mechanism anti-anginal agent with adenosine triphosphate sensitive potassium (K ATP ) channel agonist and…”
    Get full text
    Journal Article
  2. 2

    Effect of evolocumab therapy on coronary fibrous cap thickness assessed by optical coherence tomography in patients with acute coronary syndrome by Yano, Hideki, Horinaka, Shigeo, Ishimitsu, Toshihiko

    Published in Journal of cardiology (01-03-2020)
    “…•.PCSK9-inhibitor provided a greater decrease in serum low-density lipoprotein cholesterol compared with statin monotherapy.•Fibrous cap (FC) thickness…”
    Get full text
    Journal Article
  3. 3

    Factor Xa inhibitors in clinical practice: Comparison of pharmacokinetic profiles by Goto, Eri, Horinaka, Shigeo, Ishimitsu, Toshihiko, Kato, Toru

    Published in Drug metabolism and pharmacokinetics (01-02-2020)
    “…The anticoagulant actions of oral direct factor Xa (FXa) inhibitors can be inferred from their observed plasma concentrations; however, the steady-state…”
    Get full text
    Journal Article
  4. 4

    Factor Xa inhibition by rivaroxaban in the trough steady state can significantly reduce thrombin generation by Horinaka, Shigeo, Sugawara, Rie, Yonezawa, Yutaka, Ishimitsu, Toshihiko

    Published in British journal of clinical pharmacology (01-01-2018)
    “…Aims The aim of the present study was to demonstrate evidence of reduced thrombin generation at the trough plasma rivaroxaban concentration. Methods A…”
    Get full text
    Journal Article
  5. 5

    Estimated glomerular filtration ratio is a better index than creatinine clearance (Cockcroft-Gault) for predicting the prevalence of atrial fibrillation in the general Japanese population by Yonezawa, Yutaka, Horinaka, Shigeo, Shirakawa, Chiaki, Kogure, Yoshio

    Published in Hypertension research (01-06-2018)
    “…Direct oral anti-coagulants (DOACs) have been used in patients with non-valvular atrial fibrillation (AF), and renal function evaluation using the CCr…”
    Get full text
    Journal Article
  6. 6

    Impact of everolimus-eluting stent length on long-term clinical outcomes of percutaneous coronary intervention by Yano, Hideki, Horinaka, Shigeo, Ishimitsu, Toshihiko

    Published in Journal of cardiology (01-05-2018)
    “…•The long everolimus-eluting stent for ultra-long lesions was associated with favorable clinical outcomes.•In the long stent cases, major adverse cardiac event…”
    Get full text
    Journal Article
  7. 7

    Comparison of the vessel healing process after everolimus-eluting stent and bare metal stent implantations in patients with ST-elevation myocardial infarction by Yano, Hideki, Horinaka, Shigeo, Watahik, Manami, Watanabe, Tomoko, Ishimitsu, Toshihiko

    Published in Heart and vessels (01-04-2019)
    “…Cobalt–chromium everolimus-eluting stent (CoCr EES) is associated with a lower rate of stent thrombosis even in patients with ST-elevation myocardial…”
    Get full text
    Journal Article
  8. 8

    Five-year outcomes after first- and second-generation drug-eluting stent implantation in all patients undergoing percutaneous coronary intervention by Yano, Hideki, Horinaka, Shigeo, Watahiki, Manami, Watanabe, Tomoko, Ishimitsu, Toshihiko

    Published in Journal of cardiology (01-08-2019)
    “…•At 5 years, target lesion revascularization was significantly lower in the everolimus-eluting stent (EES) group than in the sirolimus-eluting stent (SES)…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Efficacy of everolimus-eluting stent implantation in patients with small coronary arteries (≤2.5 mm): outcomes of 3-year clinical follow-up by Yano, Hideki, Horinaka, Shigeo, Ishikawa, Mayuko, Ishimitsu, Toshihiko

    Published in Heart and vessels (01-07-2017)
    “…Previous studies have demonstrated that patients with small coronary artery lesions are at increased risk for late cardiac events after percutaneous coronary…”
    Get full text
    Journal Article
  11. 11

    The efficacy of everolimus-eluting stent implantation in patients with ST-segment elevation myocardial infarction: outcomes of 2-year clinical follow-up by Yano, Hideki, Horinaka, Shigeo, Ishikawa, Mayuko, Ishimitsu, Toshihiko

    Published in Heart and vessels (01-10-2016)
    “…First-generation drug-eluting stents (DES) demonstrated delay in vascular healing and increase in incidence of late and very late stent thrombosis compared…”
    Get full text
    Journal Article
  12. 12

    Associations Between Cardio–Ankle Vascular Index and Aortic Structure and Sclerosis Using Multidetector Computed Tomography by Horinaka, Shigeo, Yagi, Hiroshi, Fukushima, Hiromichi, Shibata, Yoshimasa, Takeshima, Hiroshi, Ishimitsu, Toshihiko

    Published in Angiology (01-04-2017)
    “…Aortic pulse wave velocity (PWV) has been accepted as the gold standard for arterial stiffness measurement. However, PWV depends on blood pressure (BP). To…”
    Get full text
    Journal Article
  13. 13

    Central blood pressure estimation by using N-point moving average method in the brachial pulse wave by Sugawara, Rie, Horinaka, Shigeo, Yagi, Hiroshi, Ishimura, Kimihiko, Honda, Takeharu

    Published in Hypertension research (01-05-2015)
    “…Recently, a method of estimating the central systolic blood pressure (C-SBP) using an N-point moving average method in the radial or brachial artery waveform…”
    Get full text
    Journal Article
  14. 14

    Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in patients on hemodialysis by Yano, Hideki, Horinaka, Shigeo, Yagi, Hiroshi, Ishimitsu, Toshihiko

    Published in Heart and vessels (01-05-2013)
    “…Because systemic inflammation after coronary intervention places patients at increased risk of subsequent cardiac events, we aimed to compare clinical outcomes…”
    Get full text
    Journal Article
  15. 15

    Comparison of Atherosclerotic Indicators between Cardio Ankle Vascular Index and Brachial Ankle Pulse Wave Velocity by Horinaka, Shigeo, Yabe, Akihisa, Yagi, Hiroshi, Ishimura, Kimihiko, Hara, Hitoshi, Iemua, Tomoyuki, Matsuoka, Hiroaki

    Published in Angiology (01-08-2009)
    “…Background Aortic pulse wave velocity has been used for evaluating atherosclerosis. Recently, the development of the volume plethysmographic method has made it…”
    Get full text
    Journal Article
  16. 16

    Successful implantation of leadless pacemaker in patient with the Günther Tulip inferior vena cava filter by Matsuhashi, Noritaka, Suzuki, Naoko, Goto, Eri, Murayama, Yoshiki, Hasegawa, Komi, Horinaka, Shigeo

    Published in Journal of cardiology cases (01-02-2019)
    “…Leadless pacemakers have many advantages for some patients in preventing lead- and pocket-related complications. The traveling of the femoral vein is important…”
    Get full text
    Journal Article
  17. 17

    Effects of Nicorandil on Cardiovascular Events in Patients With Coronary Artery Disease in The Japanese Coronary Artery Disease (JCAD) Study by Horinaka, Shigeo, Yabe, Akihisa, Yagi, Hiroshi, Ishimitsu, Toshihiko, Yamazaki, Tsutomu, Suzuki, Shinya, Kohro, Takahide, Nagai, Ryozo, Investigators, The JCAD Study

    Published in Circulation Journal (01-03-2010)
    “…Background: Nicorandil has cardioprotective effects in the ischemic myocardium, mimicking ischemic preconditioning, and is thus expected to improve the…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Cardio-Ankle Vascular Index Could Reflect Plaque Burden in the Coronary Artery by Horinaka, Shigeo, Yabe, Akihisa, Yagi, Hiroshi, Ishimura, Kimihiko, Hara, Hitoshi, Iemura, Tomomi, Ishimitsu, Toshihiko

    Published in Angiology (01-07-2011)
    “…Cardio-ankle vascular index (CAVI) using the volume plethysmographic method is a noninvasive atherosclerotic indicator which is not influenced by blood…”
    Get full text
    Journal Article
  20. 20